R. Casaburi, Rationale for anabolic therapy to facilitate rehabilitation in chronic obstructive pulmonary disease, BAIL CLIN E, 12(3), 1998, pp. 407-418
Chronic obstructive pulmonary disease (COPD) afflicts millions of people an
d is severely disabling. Exercise intolerance is usually the chief complain
t. There are few effective therapies, Pulmonary rehabilitation seeks to ret
urn the patient to the highest possible level of function but cannot revers
e the underlying pulmonary abnormalities. Several lines of evidence have re
cently pointed to abnormalities of the muscles of ambulation as a remediabl
e source of exercise intolerance in COPD. Possible mechanisms of the muscle
abnormalities include deconditioning, malnutrition, low levels of anabolic
hormones and, perhaps, a specific myopathy. To date, most reports of attem
pts to reverse muscle dysfunction in COPD have focused on exercise training
. However, abnormalities in the level of circulating anabolic hormones have
recently been described, suggesting that anabolic hormone supplementation
may be rational therapy for these patients. Accumulating evidence that anab
olic steroids increase muscle mass and improve strength in older men is enc
ouraging trials of anabolic steroids in men with COPD.